A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.

The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.

Pakistan-Indonesia joint exercise 'Elang Strike-III' concludes at Pabbi
- 15 گھنٹے قبل

Satya Nadella says he’s AGI-pilled now
- 2 گھنٹے قبل

Listen to this: Armand Hammer’s Snakes & Ladders
- 2 گھنٹے قبل

FBI, US Agriculture Department breached by hackers: reports
- 12 گھنٹے قبل
COLTS release QB Daniel Jones...
- ایک گھنٹہ قبل

How Uruguay built a national care system from the ground up
- 15 گھنٹے قبل

Teachers are reeling from an existential crisis. You’re probably feeling it too.
- 15 گھنٹے قبل

EU proposes tax on Big Tech to boost budget
- 9 گھنٹے قبل

PCB announces central contracts for 38 men's cricketers with key players absent
- 14 گھنٹے قبل

Oh, Elon Musk is ‘moderate’ now, is he?
- 17 گھنٹے قبل

Canva adds an AI ‘off’ button
- 17 گھنٹے قبل

Zelensky reaffirms Ukraine's wish to join NATO
- 9 گھنٹے قبل
















